Tracking blood sugar has never been more accessible — or more varied. Whether you're managing Type 1 or Type 2 diabetes, exploring metabolic health, or trying to understand how food affects your energy, the right monitor depends heavily on your health situation, how you plan to use it, and what your insurance will actually cover.
Here's what to understand before you shop.
The biggest distinction in blood sugar monitoring comes down to two categories.
Blood Glucose Monitors (BGMs) — sometimes called glucometers — are the traditional finger-stick devices. You prick your finger, apply blood to a test strip, and get a reading in seconds. They're accurate, widely available, and generally inexpensive upfront. The ongoing cost is in the test strips, which add up quickly depending on how often you test.
Continuous Glucose Monitors (CGMs) are wearable sensors — typically placed on the back of the arm or abdomen — that measure glucose levels in the fluid just beneath the skin, sending readings to a smartphone or receiver every few minutes. CGMs show you trends in real time: whether your blood sugar is rising, falling, or stable, not just what it is at a single moment.
That trend data is what makes CGMs particularly useful for people who need tight glucose management, and increasingly popular with people interested in metabolic health more broadly.
Not every feature matters equally to every person. Here's what to evaluate:
| Feature | Why It Matters | Who Cares Most |
|---|---|---|
| Warm-up / calibration time | CGMs may require a startup period before readings are reliable | People who need consistent data from day one |
| Wear duration | CGM sensors last anywhere from roughly 10 to 15+ days | Those managing costs or hating frequent changes |
| Scanning vs. automatic | Some CGMs require you to scan to get a reading; others push readings automatically | Preference and lifestyle |
| Smartphone integration | Syncs data to apps for logging and sharing with providers | Tech-comfortable users, caregivers |
| Alarm alerts | Alerts for highs and lows | Anyone at risk of hypoglycemia |
| Accuracy (MARD rating) | Lower Mean Absolute Relative Difference = more accurate | Everyone, but especially insulin users |
| No-finger-stick approval | Some CGMs are FDA-cleared to replace finger sticks; others are adjunctive only | People managing daily insulin dosing |
BGMs have their own relevant features: strip cost, strip availability, test speed, memory storage, and whether the device connects to an app.
Costs vary widely depending on device type, brand, and how you obtain it.
BGMs tend to have a low device cost — often under $30 for the meter itself — but test strips are where ongoing expenses accumulate. If you're testing multiple times daily, strip costs can reach hundreds of dollars per month without coverage.
CGMs involve a higher per-sensor cost, but because they replace frequent finger sticks and provide far more data points, the cost comparison isn't always straightforward. For people who test frequently, a CGM may not cost dramatically more over time than strips — especially with insurance.
Key cost factors:
Avoid locking in assumptions about what something costs without checking your specific plan, because the same CGM can range from nearly free with insurance to several hundred dollars per month out of pocket.
Coverage is one of the most important — and most confusing — parts of the equation.
For people with Type 1 or insulin-dependent Type 2 diabetes, CGM coverage through private insurance and Medicare has expanded substantially. Medicare Part B covers CGMs that meet specific criteria, including being prescribed by a physician and meeting certain usage thresholds. Part D covers some CGMs differently. The rules are specific and worth confirming with your insurer or a diabetes care specialist.
For people with non-insulin-treated Type 2 diabetes, coverage is less consistent. Some insurers cover CGMs in this group; others don't, or cover them only under certain conditions.
For people without diabetes using CGMs for general wellness or metabolic insight, insurance typically does not cover the cost. This is an important distinction: CGMs marketed for metabolic health awareness are generally a cash-pay decision.
What to verify with your insurer:
Your prescribing physician's office can often help navigate prior authorization, which is commonly required for CGM coverage.
The CGM market has evolved considerably. A few developments are shaping 2025 options:
Over-the-counter CGMs — devices sold without a prescription — have become available in recent years. These are designed primarily for people without diabetes who want to observe how their body responds to food, exercise, and sleep. They're typically not covered by insurance and are positioned as wellness tools rather than medical devices.
Extended-wear sensors have pushed wear time longer, reducing the frequency of sensor changes and, for some users, per-day cost.
Integrated CGM-insulin pump systems — sometimes called closed-loop or artificial pancreas systems — automate insulin delivery based on CGM readings. These are primarily relevant to people with Type 1 diabetes and require coordination between device systems and medical oversight.
The right monitor isn't universal — it depends on:
Someone managing Type 1 diabetes on an insulin pump has entirely different needs than someone with prediabetes trying to understand how different meals affect their glucose. Both might benefit from monitoring, but the appropriate device — and whether insurance will pay for it — will differ substantially.
Your care team is the right starting point for matching device type to medical need. If cost and coverage are the sticking point, a diabetes educator or the device manufacturer's patient support line can help identify options your insurer may cover or reduce out-of-pocket exposure.
